Insider transactions

EDGAR

Taysha Gene Therapies, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-16.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
12 transactions, 1,368,795 shares
Sum of shares × price per share: 6,658,093.26

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–38 of 38

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-07-10 Filed 2026-07-10Nagendran Sukumar Director · Officer: President and Head of RD
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)200,0006.24
1,248,000

Derived: shares × price per share. Exact value 1248000.00.

936,410Direct (D) Yes
F1, F2
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025.
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.99 to $6.52 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001665124-26-000013 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Long Alison S Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,3350—127,178Direct (D) No
F1
  • F1 Represents a restricted stock unit (RSU) award. The RSUs will vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Open filing 0001891712-26-000002 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Long Alison S Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (42,671) — exercise price 5.97
Acquired (A)42,6710—42,671Direct (D) No
F2
  • F2 The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Open filing 0001891712-26-000002 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Sepp-Lorenzino Laura Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,3350—127,178Direct (D) No
F1
  • F1 Represents a restricted stock unit (RSU) award. The RSUs will vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Open filing 0001777421-26-000005 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Sepp-Lorenzino Laura Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (42,671) — exercise price 5.97
Acquired (A)42,6710—42,671Direct (D) No
F2
  • F2 The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Open filing 0001777421-26-000005 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Donenberg Phillip B. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,3350—241,289Direct (D) No
F1
  • F1 Represents a restricted stock unit (RSU) award. The RSUs will vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Open filing 0001238120-26-000008 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Donenberg Phillip B. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (42,671) — exercise price 5.97
Acquired (A)42,6710—42,671Direct (D) No
F2
  • F2 The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Open filing 0001238120-26-000008 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Stalfort John A III Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)21,3350—1,176,559Direct (D) No
F1
  • F1 Represents a restricted stock unit (RSU) award. The RSUs will vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Open filing 0001709418-26-000002 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Stalfort John A III Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (42,671) — exercise price 5.97
Acquired (A)42,6710—42,671Direct (D) No
F3
  • F3 The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Open filing 0001709418-26-000002 Read from the filing’s XML Dispute this row
2026-04-10 Filed 2026-04-13Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)19,0211.71
32,525.91

Derived: shares × price per share. Exact value 32525.91.

1,336,410Direct (D) Yes— Open filing 0001665124-26-000011 Read from the filing’s XML Dispute this row
2026-04-10 Filed 2026-04-13Nagendran Sukumar Director · Officer: President and Head of RD
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)200,0004.46
892,000

Derived: shares × price per share. Exact value 892000.00.

1,136,410Direct (D) Yes
F1, F2
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025.
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.335 to $4.625 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001665124-26-000011 Read from the filing’s XML Dispute this row
2026-04-10 Filed 2026-04-13Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (19,021) — exercise price 1.71
Disposed (D)19,0210—455,920Direct (D) Yes
F3
  • F3 25% of the total number of shares underlying the option vested and became exercisable on January 2, 2025 and the remainder vested or shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001665124-26-000011 Read from the filing’s XML Dispute this row
2026-02-04 Filed 2026-02-06Alam Kamran Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,6554.52
7,480.6

Derived: shares × price per share. Exact value 7480.60.

1,442,131Direct (D) No
F1
  • F1 The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.
Open filing 0001793412-26-000012 Read from the filing’s XML Dispute this row
2026-01-26 Filed 2026-01-27Nagendran Sukumar Director · Officer: President and Head of RD
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)26,9184.61
124,091.98

Derived: shares × price per share. Exact value 124091.98.

1,317,389Direct (D) No
F1, F3
  • F1 The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.
  • F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.715 inclusive.
Open filing 0001665124-26-000008 Read from the filing’s XML Dispute this row
2026-01-26 Filed 2026-01-27Nolan Sean P. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)41,3124.61
190,448.32

Derived: shares × price per share. Exact value 190448.32.

2,908,257Direct (D) No
F1, F3
  • F1 The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.
  • F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.715 inclusive.
Open filing 0001569926-26-000008 Read from the filing’s XML Dispute this row
2026-01-26 Filed 2026-01-27Alam Kamran Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)23,8494.61
109,943.89

Derived: shares × price per share. Exact value 109943.89.

1,443,786Direct (D) No
F1, F3
  • F1 The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.
  • F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.715 inclusive.
Open filing 0001793412-26-000008 Read from the filing’s XML Dispute this row
2026-01-23 Filed 2026-01-27Nagendran Sukumar Director · Officer: President and Head of RD
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)89,1324.75
423,377

Derived: shares × price per share. Exact value 423377.00.

1,344,307Direct (D) No
F1, F2
  • F1 The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.635 to $4.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
Open filing 0001665124-26-000008 Read from the filing’s XML Dispute this row
2026-01-23 Filed 2026-01-27Nolan Sean P. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)136,7894.75
649,747.75

Derived: shares × price per share. Exact value 649747.75.

2,949,569Direct (D) No
F1, F2
  • F1 The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.635 to $4.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
Open filing 0001569926-26-000008 Read from the filing’s XML Dispute this row
2026-01-23 Filed 2026-01-27Alam Kamran Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)78,9684.75
375,098

Derived: shares × price per share. Exact value 375098.00.

1,467,635Direct (D) No
F1, F2
  • F1 The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.635 to $4.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
Open filing 0001793412-26-000008 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Nolan Sean P. Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)1,008,0000—3,086,358Direct (D) No
F1
  • F1 Represents a restricted stock unit (RSU) award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001569926-26-000002 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Nolan Sean P. Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (648,000) — exercise price 4.86
Acquired (A)648,0000—648,000Direct (D) No
F3
  • F3 25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001569926-26-000002 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)111,3240.6989
77,804.3436

Derived: shares × price per share. Exact value 77804.3436.

1,117,763Direct (D) Yes— Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)88,6761.71
151,635.96

Derived: shares × price per share. Exact value 151635.96.

1,206,439Direct (D) Yes— Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Nagendran Sukumar Director · Officer: President and Head of RD
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)200,0004.71
942,000

Derived: shares × price per share. Exact value 942000.00.

1,006,439Direct (D) Yes
F1, F2
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025.
  • F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.565 to $4.92 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Nagendran Sukumar Director · Officer: President and Head of RD
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)427,0000—1,433,439Direct (D) Yes
F3
  • F3 Represents a restricted stock unit (RSU) award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (111,324) — exercise price 0.6989
Disposed (D)111,3240—111,359Direct (D) Yes
F4
  • F4 The shares underlying the option vested or shall vest and become exercisable in three equal annual installments commencing on December 31, 2024, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (88,676) — exercise price 1.71
Disposed (D)88,6760—474,941Direct (D) Yes
F5
  • F5 25% of the total number of shares underlying the option vested and became exercisable on January 2, 2025 and the remainder vested or shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Nagendran Sukumar Director · Officer: President and Head of RD
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (274,000) — exercise price 4.86
Acquired (A)274,0000—274,000Direct (D) Yes
F6
  • F6 25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Alam Kamran Officer: CHIEF FINANCIAL OFFICER
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)359,0000—1,546,603Direct (D) No
F1
  • F1 Represents a restricted stock unit (RSU) award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001793412-26-000002 Read from the filing’s XML Dispute this row
2026-01-12 Filed 2026-01-14Alam Kamran Officer: CHIEF FINANCIAL OFFICER
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (231,000) — exercise price 4.86
Acquired (A)231,0000—231,000Direct (D) No
F2
  • F2 25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001793412-26-000002 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-01Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)260,0471.71
444,680.37

Derived: shares × price per share. Exact value 444680.37.

1,266,486Direct (D) No— Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-01Nagendran Sukumar Director · Officer: President and Head of RD
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)260,0474.51
1,172,811.97

Derived: shares × price per share. Exact value 1172811.97.

1,006,439Direct (D) No
F2
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.42 to $4.63 inclusive.
Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-01Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (260,047) — exercise price 1.71
Disposed (D)260,0470—563,617Direct (D) No
F4
  • F4 25% of the total number of shares underlying the option vested and became exercisable on January 2, 2025 and the remainder vested or shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row
2025-11-28 Filed 2025-12-01Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)70,1720.6989
49,043.2108

Derived: shares × price per share. Exact value 49043.2108.

1,076,611Direct (D) No— Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row
2025-11-28 Filed 2025-12-01Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)39,9531.71
68,319.63

Derived: shares × price per share. Exact value 68319.63.

1,116,564Direct (D) No— Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row
2025-11-28 Filed 2025-12-01Nagendran Sukumar Director · Officer: President and Head of RD
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)110,1254.75
523,093.75

Derived: shares × price per share. Exact value 523093.75.

1,006,439Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.7248 to $4.8348 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2).
Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row
2025-11-28 Filed 2025-12-01Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (70,172) — exercise price 0.6989
Disposed (D)70,1720—222,683Direct (D) No
F3
  • F3 The shares underlying the option vested or shall vest and become exercisable in three equal annual installments commencing on December 31, 2024, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row
2025-11-28 Filed 2025-12-01Nagendran Sukumar Director · Officer: President and Head of RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (39,953) — exercise price 1.71
Disposed (D)39,9530—823,664Direct (D) No
F4
  • F4 25% of the total number of shares underlying the option vested and became exercisable on January 2, 2025 and the remainder vested or shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
RA Capital Management, L.P. Common Stock, $0.00001 par value per share9.932,886,242.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 5Open filing 0001231919-26-000928 Dispute this row
Peter Kolchinsky Common Stock, $0.00001 par value per share9.932,886,242.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 5Open filing 0001231919-26-000928 Dispute this row
Rajeev Shah Common Stock, $0.00001 par value per share9.932,886,242.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 5Open filing 0001231919-26-000928 Dispute this row
RA Capital Healthcare Fund, L.P. Common Stock, $0.00001 par value per share9.932,886,242.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 5Open filing 0001231919-26-000928 Dispute this row
Morgan Stanley Common Stock5.116,244,33906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 2Open filing 0000895421-26-000269 Dispute this row
Morgan Stanley Capital Services LLC Common Stock5.016,001,13006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 2Open filing 0000895421-26-000269 Dispute this row
Vestal Point Capital, LP Common Stock, par value $0.00001 per share6.318,000,000.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000902664-26-002553 Dispute this row
Ryan Wilder Common Stock, par value $0.00001 per share6.318,000,000.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000902664-26-002553 Dispute this row
RTW Investments, LP Common Stock, par value $0.00001 per share7.020,689,084.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 5Open filing 0001493215-26-000122 Dispute this row
Roderick Wong Common Stock, par value $0.00001 per share7.020,689,084.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 5Open filing 0001493215-26-000122 Dispute this row
RTW Investments, LP Common Stock, par value $0.00001 per share8.323,407,133.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 4Open filing 0001493215-26-000050 Dispute this row
Roderick Wong Common Stock, par value $0.00001 per share8.323,407,133.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 4Open filing 0001493215-26-000050 Dispute this row
Vestal Point Capital, LP Common Stock, par value $0.00001 per share513,750,000.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0000902664-26-001081 Dispute this row
Ryan Wilder Common Stock, par value $0.00001 per share513,750,000.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0000902664-26-001081 Dispute this row
FMR LLC COMMON STOCK4.913,528,365.8712/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 10Open filing 0000315066-26-000536 Dispute this row
Abigail P. Johnson COMMON STOCK4.913,528,365.8712/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 10Open filing 0000315066-26-000536 Dispute this row
BlackRock, Inc. Common Stock6.517,852,29112/31/2025 Filed 2026-01-21SCHEDULE 13G/AAmendment 2Open filing 0002012383-26-000794 Dispute this row
RA Capital Management, L.P. Common Stock, $0.00001 par value per share9.927,662,481.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0001231919-25-000491 Dispute this row
Peter Kolchinsky Common Stock, $0.00001 par value per share9.927,662,481.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0001231919-25-000491 Dispute this row
Rajeev Shah Common Stock, $0.00001 par value per share9.927,662,481.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0001231919-25-000491 Dispute this row
RA Capital Healthcare Fund, L.P. Common Stock, $0.00001 par value per share9.927,662,481.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 4Open filing 0001231919-25-000491 Dispute this row
Octagon Capital Advisors LP Common Stock, $0.00001 par value3.39,067,500.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016718 Dispute this row
Octagon Investments Master Fund Common Stock, $0.00001 par value3.39,067,500.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016718 Dispute this row
Ting Jia Common Stock, $0.00001 par value3.39,067,500.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016718 Dispute this row
RA Capital Management, L.P. Common Stock, $0.00001 par value per share9.925,345,988.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-022033 Dispute this row
Peter Kolchinsky Common Stock, $0.00001 par value per share9.925,345,988.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-022033 Dispute this row
Rajeev Shah Common Stock, $0.00001 par value per share9.925,345,988.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-022033 Dispute this row
RA Capital Healthcare Fund, L.P. Common Stock, $0.00001 par value per share9.925,345,988.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-022033 Dispute this row
RTW Investments, LP Common Stock, par value $0.00001 per share9.925,183,287.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-021712 Dispute this row
Roderick Wong Common Stock, par value $0.00001 per share9.925,183,287.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-021712 Dispute this row
FMR LLC COMMON STOCK6.215,627,821.8706/30/2025 Filed 2025-08-06SCHEDULE 13G/AAmendment 9Open filing 0000315066-25-002098 Dispute this row
Abigail P. Johnson COMMON STOCK6.215,627,821.8706/30/2025 Filed 2025-08-06SCHEDULE 13G/AAmendment 9Open filing 0000315066-25-002098 Dispute this row
Morgan Stanley Common Stock6.716,858,64406/30/2025 Filed 2025-08-06SCHEDULE 13G/AAmendment 1Open filing 0000895421-25-000463 Dispute this row
Morgan Stanley Capital Services LLC Common Stock5.614,095,14306/30/2025 Filed 2025-08-06SCHEDULE 13G/AAmendment 1Open filing 0000895421-25-000463 Dispute this row
BlackRock, Inc. Common Stock5.213,153,32606/30/2025 Filed 2025-07-16SCHEDULE 13G/AAmendment 1Open filing 0002052113-25-002549 Dispute this row
THE GOLDMAN SACHS GROUP, INC. Common Stock, par value $0.00001 per share5.112,748,968.0006/26/2025 Filed 2025-07-03SCHEDULE 13GOpen filing 0000769993-25-000401 Dispute this row
GOLDMAN SACHS CO. LLC Common Stock, par value $0.00001 per share5.112,748,968.0006/26/2025 Filed 2025-07-03SCHEDULE 13GOpen filing 0000769993-25-000401 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,093,437 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
2024186,415
2025235,520
2026254,737

Filings made before the SEC required XML are listed, not extracted.

Back to Taysha Gene Therapies, Inc.